SMAD5 and cancer: Because treatment with PTX induces G2/M cell cycle arrest in chemosensitive cancer cells [40], MDA-MB 231 cells were treated with PTX and/or siRNAs targeting SMAD5 (Scramble siRNAs were used as control) and cell cycle profile was analyzed by FACS assay.